Table 1.

Patient and Donor HLA Types

Patient/DonorCell DescriptionHLA-AHLA-BHLA-DR
 
CTL1 CTL line 1 1,2 8,27 3,16 
CTL2 CTL line 2 2,29 44,60 4,7 
D1 Normal marrow 1,2 35,58 4,16 
D2 Normal marrow 2,28 35,41 9,14 
D3 Normal marrow 2,26 13,58 7,7 
D4 Normal marrow 1,2 63,63 13,8 
D5 Normal marrow 1,28 14,38 7,14 
P1 CML-CP 1,2 35,58 4,16 
P2 CML-BC 2,28 35,41 9,14 
P3 CML-BC 2,26 13,58 7,7 
P4 CML-AP 1,2 63,63 13,8 
P5 CML-CP 1,28 14,38 7,14 
Patient/DonorCell DescriptionHLA-AHLA-BHLA-DR
 
CTL1 CTL line 1 1,2 8,27 3,16 
CTL2 CTL line 2 2,29 44,60 4,7 
D1 Normal marrow 1,2 35,58 4,16 
D2 Normal marrow 2,28 35,41 9,14 
D3 Normal marrow 2,26 13,58 7,7 
D4 Normal marrow 1,2 63,63 13,8 
D5 Normal marrow 1,28 14,38 7,14 
P1 CML-CP 1,2 35,58 4,16 
P2 CML-BC 2,28 35,41 9,14 
P3 CML-BC 2,26 13,58 7,7 
P4 CML-AP 1,2 63,63 13,8 
P5 CML-CP 1,28 14,38 7,14 

Abbreviations: CTL1, cytotoxic T lymphocytes derived from a normal donor; CTL2, cytotoxic T lymphocytes derived from a second normal donor; CML-CP, chronic myelogenous leukemia, chronic phase; CML-AP, chronic myelogenous leukemia, accelerated phase; CML-BC, chronic myelogenous leukemia, blast crisis.

View Large